Skip to main content

Spastic Cerebral Palsy

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

LiNA MEDICAL
LiNA MEDICALDenmark - Naerum
1 program
3-Minute Walking Gait and Surface Electromyography AssessmentN/A1 trial
Active Trials
NCT07316985Completed72Est. Dec 2024
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Selective movement of individual lower limb jointsN/A1 trial
Active Trials
NCT07310550Completed23Est. Jan 2019
Verona Pharma
Verona PharmaUK - London
1 program
IncobotulinumtoxinA 100 UNT [Xeomin]PHASE_21 trial
Active Trials
NCT05340439Unknown30Est. May 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Verona PharmaIncobotulinumtoxinA 100 UNT [Xeomin]
LiNA MEDICAL3-Minute Walking Gait and Surface Electromyography Assessment
Angeles TherapeuticsSelective movement of individual lower limb joints

Clinical Trials (3)

Total enrollment: 125 patients across 3 trials

NCT05340439Verona PharmaIncobotulinumtoxinA 100 UNT [Xeomin]

INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT)

Start: Jun 2022Est. completion: May 202530 patients
Phase 2Unknown
NCT07316985LiNA MEDICAL3-Minute Walking Gait and Surface Electromyography Assessment

Efficacy of Physical Fitness Training Combined With Exercise Therapy on Gait in Children With Cerebral Palsy

Start: Jun 2023Est. completion: Dec 202472 patients
N/ACompleted
NCT07310550Angeles TherapeuticsSelective movement of individual lower limb joints

A Physical Therapy Program Targeting Lower Extremity Selective Motor Control in Children With Spastic Cerebral Palsy

Start: May 2014Est. completion: Jan 201923 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.